Leiden, the Netherlands, December 8, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announced its participation in the Oppenheimer Movers in Rare Disease Summit ...
Pharming Group NV stock reached a significant milestone, hitting a 52-week high at 17.89 USD. According to InvestingPro data, the stock is currently trading at 17.94 USD, slightly above this recent ...
Yes, celiac disease is a hereditary genetic condition. People with a first-degree relative, such as a parent, child, or sibling, have a 10% higher risk of developing celiac disease, according to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback